InvestorsHub Logo
Followers 120
Posts 19839
Boards Moderated 0
Alias Born 08/27/2005

Re: lasers post# 241305

Thursday, 02/02/2017 5:12:48 AM

Thursday, February 02, 2017 5:12:48 AM

Post# of 414354
Our pharmaceutical sells to healthcare, hospitals, doctors, and alike.

That was a huge acquisition by Pfizer. Very lucrative too.
Depending on the number of manufacturers involved injectable narcotics can be a big money maker if the product being sold is in short supply. Or if the product is found to need special testing.
Ketorolac requires special testing as does heparin. Big money if one has just those two drugs and there are not to many players manufacturing them.

Fentanyl, hydromorphone, morphine (with duramorh and infumorph), meperidine(Demerol), phenobarbital, the antipsychotic prochlorperizine, neostigmine....... and others all make up some of what injectable companies may carry.

Digoxin, doxapram, diphenhydramine, dexamethasone, ondansetron, dicyclomine, phenytoin, promethazine, cardene are some other injectable products that can really add to the bottom line depending on market need and saturation.

I think Elite has something much better being an oral form.
Pills and capsules will always be a huge mover in their own right.
Looking forward to Percocet, Norco, and other generics on the back burner. the first two mentioned should do very well revenue wise.




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News